Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer - Related Studies

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

This study is currently recruiting participants.

Study NCT00683358. Last updated on May 22, 2008. Information provided by Tokyo University

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pancreatic Cancer
		Pancreas Neoplasms
		Cancer of Pancreas
		Neoplasms, Pancreatic
		Pancreas Cancer

2	Additional conditions recognized in this trial
		Neoplasms
		Pancreatic Neoplasms

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Neoplasms by Site
		Pancreatic Diseases

4	Interventions listed in this trial
		VEGFR1-A24-1084 (SYGVLLWEI)

5	Additional drug interventions recognized in this trial
		Gemcitabine

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Tokyo University
		Human Genome Center, Institute of Medical Science, University of Tokyo